Developmental Pharmacology and Toxicology: Role of Ontogeny (R21)

The summary for the Developmental Pharmacology and Toxicology: Role of Ontogeny (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Developmental Pharmacology and Toxicology: Role of Ontogeny (R21): This Funding Opportunity Announcement (FOA) encourages grant applications for research related to developmental pharmacology and toxicology. A major goal is to encourage multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology and toxicology with particular emphasis on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways across developmental periods from fetal life to adolescence.

Federal Grant Title:	Developmental Pharmacology and Toxicology: Role of Ontogeny (R21)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Environment Health Income Security and Social Services
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-13-308
Type of Funding:	Grant
CFDA Numbers:	93.113, 93.865
CFDA Descriptions:	Environmental Health; Child Health and Human Development Extramural Research
Current Application Deadline:	Sep 07, 2016
Original Application Deadline:	Sep 07, 2016
Posted Date:	Aug 05, 2013
Creation Date:	Aug 07, 2013
Archive Date:	Oct 08, 2016
Total Program Funding:
Maximum Federal Grant Award:	$200,000
Minimum Federal Grant Award:	none
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
City or township governments
Public and State controlled institutions of higher education
Private institutions of higher education
Independent school districts
Small businesses
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
County governments
For profit organizations other than small businesses
State governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Special district governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PAR-13-308.html
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants: • Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clini...; • Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic ...; • Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clini...; • Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed); • Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...; • Outstanding New Environmental Scientist Award (ONES); • Environmental Health Sciences Core Center Grants; • Leiomyomata Uteri: Basic Science and Translational Research
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...